how were glp 1 agonists discovered Evolution of GLP‐1 Receptor for Diabetes Treatment Discovery of GLP-1–Based Drugs for
Description
However, context matters here
108466-89-3, Boc-NH-PEG2-CH2COOH CAS No
Wilmington, DE: AstraZeneca Pharmaceuticals LP
Back de Levia-Hidalgo, A, de Leviva-Prez, A (Oct 2019) 'Pancreatic extracts for the treatment of diabetes (18891914): Acomatol', American Journal of Therapeutics , 27, 21-e12
For all their promise, GLP-1 and dual GIP/GLP-1 receptor agonists have raised more questions, particularly regarding their long-term safety implications
